Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ Crry Polyclonal Antibody
GREENER_CHOICE

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA545763

Catalog No. PIPA545763


Only null left
Add to Cart

Description

Description

Peptide sequence: ALNKWEPELP SCSRVCQPPP DVLHAERTQR DKDNFSPGQE VFYSCEPGYD Sequence homology: Human: 100%.

This gene encodes a membrane-bound inhibitor of complement activation, which contains several tandemly arranged short consensus repeats (SCRs) of approximately 60 amino acids. The encoded protein may play a role in tumor immune surveillance, which is unrelated to complement inhibition. Three alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Crry
Polyclonal
Unconjugated
CR1L
5I2 antigen; antigen 5I2; complement C3b/C4b receptor 1 like; complement C4b-binding protein CR-1-like protein; complement component (3b/4b) receptor 1-like; complement component 3b/4b receptor 1-like; complement component receptor 1-like protein; Complement receptor related protein; complement receptor type 1; complement regulatory protein Crry; Cr1; CR1L; Crry; Cry; Mcp; mCRY; MGC129536; protein p65
Rabbit
Affinity Chromatography
RUO
1379
-20°C, Avoid Freeze/Thaw Cycles
Liquid
Western Blot
0.5 mg/mL
PBS with 2% sucrose and 0.09% sodium azide
Q2VPA4
CR1L
Synthetic peptide directed towards the middle region of human CR1L.
100 μL
Primary
Human
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.